This coming January will mark two years since we launched Tech Frontiers and its predecessor, Biotech Frontiers. During that time, we’ve compiled an extraordinary track record: Eight of our recommendations have appreciated over 100% and many others have appreciated at least 50%. In the meantime, in our biotech portfolio, we encountered only two meaningful losers
This month’s recommendation looks at a real estate investment trust, or REIT, that has a very low level of risk, and that is supported by a huge dividend that is well above almost any fixed-income instrument in the market today.
Today, Porter warns that a popular retailer has begun a terminal decline – much like he correctly predicted for Sears and J.C. Penney years ago – that will end in bankruptcy by the end of the decade.
Learn how to use this Forum, what it’s for, what questions we may be able to answer or not, and other details.
Here you’ll find official notices, buy and sell alerts, updates and anything else that we want you to know.
Ask questions or simply discuss the reasoning and investment thesis behind any of our official Trading Club trades.
Did your trade turn out differently than the official Trading Club trade? Do you have questions about the mechanics of a trade?
Discover investing ideas from fellow Trading Club members or post your own. Please note that these are not official recommendations and none of the trade ideas have been vetted by any Porter & Co. staff member.
Today, Porter shares the one investing secret that he plans to share with his kids. Here’s the best part for you. If a significant portion of your wealth is invested this way, you never have to worry about what the market is going to do.
In our report Dig Baby Dig, published on September 12, 2024, we recommended purchasing Albemarle’s 7.25% Series A Mandatory Convertible Preferred Stock, then trading at $42.89 per share. Our rationale was that the sharp decline in lithium prices had caused the stock prices of the companies, like Albemarle, that produce it, to fall too far.